These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 19035880)
1. Pharmacological profile of the selective mitochondrial F1F0 ATP hydrolase inhibitor BMS-199264 in myocardial ischemia. Grover GJ; Malm J Cardiovasc Ther; 2008; 26(4):287-96. PubMed ID: 19035880 [TBL] [Abstract][Full Text] [Related]
2. Energetic signalling in the control of mitochondrial F1F0 ATP synthase activity in health and disease. Grover GJ; Marone PA; Koetzner L; Seto-Young D Int J Biochem Cell Biol; 2008; 40(12):2698-701. PubMed ID: 18707016 [TBL] [Abstract][Full Text] [Related]
3. Excessive ATP hydrolysis in ischemic myocardium by mitochondrial F1F0-ATPase: effect of selective pharmacological inhibition of mitochondrial ATPase hydrolase activity. Grover GJ; Atwal KS; Sleph PG; Wang FL; Monshizadegan H; Monticello T; Green DW Am J Physiol Heart Circ Physiol; 2004 Oct; 287(4):H1747-55. PubMed ID: 15371268 [TBL] [Abstract][Full Text] [Related]
4. Benzodiazepine-based selective inhibitors of mitochondrial F1F0 ATP hydrolase. Hamann LG; Ding CZ; Miller AV; Madsen CS; Wang P; Stein PD; Pudzianowski AT; Green DW; Monshizadegan H; Atwal KS Bioorg Med Chem Lett; 2004 Feb; 14(4):1031-4. PubMed ID: 15013017 [TBL] [Abstract][Full Text] [Related]
5. Small molecule mitochondrial F1F0 ATPase hydrolase inhibitors as cardioprotective agents. Identification of 4-(N-arylimidazole)-substituted benzopyran derivatives as selective hydrolase inhibitors. Atwal KS; Wang P; Rogers WL; Sleph P; Monshizadegan H; Ferrara FN; Traeger S; Green DW; Grover GJ J Med Chem; 2004 Feb; 47(5):1081-4. PubMed ID: 14971888 [TBL] [Abstract][Full Text] [Related]
6. Identification of compounds that bind mitochondrial F1F0 ATPase by screening a triazine library for correction of albinism. Williams D; Jung DW; Khersonsky SM; Heidary N; Chang YT; Orlow SJ Chem Biol; 2004 Sep; 11(9):1251-9. PubMed ID: 15380185 [TBL] [Abstract][Full Text] [Related]
7. Oligomycin, inhibitor of the F0 part of H+-ATP-synthase, suppresses the TNF-induced apoptosis. Shchepina LA; Pletjushkina OY; Avetisyan AV; Bakeeva LE; Fetisova EK; Izyumov DS; Saprunova VB; Vyssokikh MY; Chernyak BV; Skulachev VP Oncogene; 2002 Nov; 21(53):8149-57. PubMed ID: 12444550 [TBL] [Abstract][Full Text] [Related]
8. N-[1-Aryl-2-(1-imidazolo)ethyl]-guanidine derivatives as potent inhibitors of the bovine mitochondrial F1F0 ATP hydrolase. Atwal KS; Ahmad S; Ding CZ; Stein PD; Lloyd J; Hamann LG; Green DW; Ferrara FN; Wang P; Rogers WL; Doweyko LM; Miller AV; Bisaha SN; Schmidt JB; Li L; Yost KJ; Lan HJ; Madsen CS Bioorg Med Chem Lett; 2004 Feb; 14(4):1027-30. PubMed ID: 15013016 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. Shin YK; Yoo BC; Chang HJ; Jeon E; Hong SH; Jung MS; Lim SJ; Park JG Cancer Res; 2005 Apr; 65(8):3162-70. PubMed ID: 15833846 [TBL] [Abstract][Full Text] [Related]
10. Preconditioning in rat hearts is independent of mitochondrial F1F0 ATPase inhibition. Green DW; Murray HN; Sleph PG; Wang FL; Baird AJ; Rogers WL; Grover GJ Am J Physiol; 1998 Jan; 274(1):H90-7. PubMed ID: 9458856 [TBL] [Abstract][Full Text] [Related]
11. Investigation of the role and mechanism of IF1 and STF1 proteins, twin inhibitory peptides which interact with the yeast mitochondrial ATP synthase. Venard R; Brèthes D; Giraud MF; Vaillier J; Velours J; Haraux F Biochemistry; 2003 Jun; 42(24):7626-36. PubMed ID: 12809520 [TBL] [Abstract][Full Text] [Related]
12. Generation of metabolic oscillations by mitoKATP and ATP synthase during simulated ischemia in ventricular myocytes. Ryu SY; Lee SH; Ho WK J Mol Cell Cardiol; 2005 Dec; 39(6):874-81. PubMed ID: 16242144 [TBL] [Abstract][Full Text] [Related]
13. Mitochondria consume energy and compromise cellular membrane potential by reversing ATP synthetase activity during focal ischemia in rats. Takeda Y; Pérez-Pinzón MA; Ginsberg MD; Sick TJ J Cereb Blood Flow Metab; 2004 Sep; 24(9):986-92. PubMed ID: 15356419 [TBL] [Abstract][Full Text] [Related]
14. Dose-dependent inhibition of mitochondrial ATP synthase by 17 beta-estradiol. Massart F; Paolini S; Piscitelli E; Brandi ML; Solaini G Gynecol Endocrinol; 2002 Oct; 16(5):373-7. PubMed ID: 12587531 [TBL] [Abstract][Full Text] [Related]
15. Mechanistic basis for therapeutic targeting of the mitochondrial F1F0-ATPase. Johnson KM; Cleary J; Fierke CA; Opipari AW; Glick GD ACS Chem Biol; 2006 Jun; 1(5):304-8. PubMed ID: 17163759 [TBL] [Abstract][Full Text] [Related]
16. The inhibitor protein (IF1) promotes dimerization of the mitochondrial F1F0-ATP synthase. García JJ; Morales-Ríos E; Cortés-Hernandez P; Rodríguez-Zavala JS Biochemistry; 2006 Oct; 45(42):12695-703. PubMed ID: 17042487 [TBL] [Abstract][Full Text] [Related]
17. Atrazine binds to F1F0-ATP synthase and inhibits mitochondrial function in sperm. Hase Y; Tatsuno M; Nishi T; Kataoka K; Kabe Y; Yamaguchi Y; Ozawa N; Natori M; Handa H; Watanabe H Biochem Biophys Res Commun; 2008 Feb; 366(1):66-72. PubMed ID: 18060860 [TBL] [Abstract][Full Text] [Related]
18. Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Imahashi K; Schneider MD; Steenbergen C; Murphy E Circ Res; 2004 Oct; 95(7):734-41. PubMed ID: 15345651 [TBL] [Abstract][Full Text] [Related]
19. Functional and molecular changes in FoF1 ATP-synthase of cardiac muscle during aging. Guerrieri F; Capozza G; Fratello A; Zanotti F; Papa S Cardioscience; 1993 Jun; 4(2):93-8. PubMed ID: 8347797 [TBL] [Abstract][Full Text] [Related]